Description

Ugresol (benzoyl peroxide) lotion 10% 30 ml Vial

Ingredients

Active ingredient: Benzoyl peroxide 10%
Other ingredients: Purified water, disodium EDTA, citric acid, propylene glycol, carbomer, sodium hydroxide

Dosage

Apply a thin layer to the affected area once or twice daily, or as directed by your healthcare provider.

Indications

Ugresol lotion is indicated for the topical treatment of acne vulgaris. It works by reducing the amount of acne-causing bacteria and by causing the skin to dry and peel.

Contraindications

Do not use Ugresol lotion if you are allergic to benzoyl peroxide or any other ingredients in the product. Avoid contact with eyes, mouth, and mucous membranes.

Directions

Cleanse the affected area before applying the lotion. Gently massage a small amount of the lotion onto the skin until absorbed. Avoid excessive exposure to sunlight or UV lamps.

Scientific Evidence

Benzoyl peroxide, the active ingredient in Ugresol lotion, has been extensively studied for its efficacy in treating acne. Research published in the Journal of Clinical and Aesthetic Dermatology has shown that benzoyl peroxide is effective in reducing inflammatory and non-inflammatory acne lesions.

Additional Information

It is important to note that benzoyl peroxide may cause skin dryness, peeling, and irritation, especially during the initial weeks of treatment. It is recommended to start with a lower concentration and gradually increase as tolerated. Consult a healthcare provider if severe irritation occurs.

Pharmacological Effects: Benzoyl peroxide exerts its action by releasing oxygen free radicals, which have antibacterial properties and help to unclog pores. This leads to a reduction in acne-causing bacteria and inflammation on the skin.

Clinical Trials: Clinical trials have demonstrated the efficacy of benzoyl peroxide in the treatment of acne, with significant improvements in acne severity and lesion count compared to placebo. One study published in the Journal of Drugs in Dermatology showed a 60% reduction in inflammatory lesions after 12 weeks of treatment with benzoyl peroxide.